Replimune (REPL) Amortization - Deferred Charges (2021 - 2026)
Powered by 
Analysis
Replimune (REPL) Amortization - Deferred Charges (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | - |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | - |
| 10 | Replimune | 1.46 Bn | 1.46 Bn | - | 289,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 289,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 288,000.00 |
| Sep 30, 2024 | 285,000.00 |
| Jun 30, 2024 | 281,000.00 |
| Dec 31, 2022 | 252,000.00 |
| Sep 30, 2022 | 252,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 267,000.00 |
| Dec 31, 2021 | 249,000.00 |
| Sep 30, 2021 | 245,000.00 |
| Jun 30, 2021 | 242,000.00 |